Alliance for Regenerative Medicine

Formed in 2009, the coalition is comprised of universities, life sciences companies, health care investors, and patient advocates with the common goal of advancing cell-based therapies. The Alliance is dedicated to promoting regulatory, research, and reimbursement policies that foster innovation in regenerative medicine. Additionally, the Alliance serves as a source of information about regenerative medicine for policy makers, the media, and the general public.